Bruker Announces Acquisition of ACQUIFER Imaging GmbH
Adding Big-Data Management and High-Content Screening Solutions for Bioimaging Applications
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230105006017/en/
Acquifer’s HIVE data management system provides image processing, high-performance computing, deep learning, and big-data storage for demanding bioresearch applications and multi-user settings. (Photo: Business Wire)
ACQUIFER's flagship HIVE™ data management systems feature a fast backbone for very high data collection speed and multicore, multi-GPU processing, as well as scalable plug-and-play storage modules up to the petabyte (PB) range. The acquisition also includes the innovative IM04 Imaging Instrument, a robust, automated high-content imaging system for reproducible phenotypic screening of cells, whole organisms, and organoids. Financial details of the transaction were not disclosed.
“Cutting-edge bioresearch often requires high-performance big-data management, which HIVE can offer,” said Dr. Peter Zehetmayer, COO and Director for Sales & Marketing at ACQUIFER. “In addition, our IM04 system expands Bruker’s fluorescence microscopy portfolio into the high-content screening arena. As part of Bruker, we anticipate the ability to greatly expand the reach of our scientific computing and imaging technologies worldwide.”
“The ACQUIFER HIVE system was developed to keep up with the ever-increasing amount of data that life science research can generate. In combination with Bruker’s fluorescence microscopy platforms, including our light-sheet microscopy instrumentation, we can now offer a holistic solution for advanced imaging and big-data management,” added Dr.
Founded in 2012 and based in Heidelberg,
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230105006017/en/
Senior Director, Investor Relations & Corporate Development
T: +1 (978) 663-3660 x1479
Content Marketing Manager
T: +1 (520) 741-1044 x1022